510(k) K171650
K171650 is an FDA 510(k) premarket notification submitted by Abbott Rapid Diagnostics for the device "Alere Afinion HbA1c and ACR on Afinion 2 analyzer". The FDA issued a decision of Substantially Equivalent on November 21, 2017. The device falls under product code LCP (Assay, Glycosylated Hemoglobin), a Class II device regulated under 21 CFR 864.7470.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- November 21, 2017
- Date Received
- June 5, 2017
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Assay, Glycosylated Hemoglobin
- Device Class
- Class II
- Regulation Number
- 864.7470
- Review Panel
- HE
- Submission Type